Liquid Pediatric Market Players:
- Johnson & Johnson
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis International AG
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Eli Lilly and Company
- AbbVie Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of liquid pediatric is evaluated at USD 12.3 billion.
The global liquid pediatric market size was worth over USD 11.49 billion in 2025 and is poised to grow at a CAGR of around 7.8%, reaching USD 24.35 billion revenue by 2035.
Asia Pacific liquid pediatric market is expected to hold the largest share of 39%, impelled by the growing importance of pediatric healthcare and rising parental awareness of medication adherence.
Key players in the market include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Merck & Co., Inc.
